NFKB1 and depressive symptom measurement: In the brain, RPP mitigates neuroinflammation by suppressing the TLR4/NF-κB signaling pathway and enhances synaptic function through activation of CREB/BDNF signaling, thereby alleviating brain inflammation triggered by gut-derived inflammatory factors crossing the BBB and improving depression-like behaviors (199).